Evidence map›Paper›PMID 30135219›Full record

ArticlemSphere2018

Two Vaccines for

Christopher D Dupont, Ingrid L Scully, Ross M Zimnisky, Brinda Monian, Christina P Rossitto, Ellen B O'Connell, Kathrin U Jansen, Annaliesa S Anderson, J Christopher Love

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in mSphere, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Pathogens (Basel, Switzerland) · 2025
    Review
  3. Conserved moonlighting protein pyruvate dehydrogenase induces robust protection againstProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  4. Antigen specific activation of cytotoxic CD8Frontiers in cellular and infection microbiology · 2023
    Article
  5. Exploring the Role ofToxins · 2022
    Review
  6. Review
  7. Review
  8. Frontiers in microbiology · 2021
    Review
  9. New developments and future challenges in prevention, diagnosis, and treatment of prosthetic joint infection.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2020
    Review
  10. Review
  11. Staphylococci: Evolving Genomes.Microbiology spectrum · 2019
    Review
  12. Genetic variation of DNA methyltransferase-3A contributes to protection against persistent MRSA bacteremia in patients.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  13. Recent advances inInfection and drug resistance · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Christopher D DupontKoch Institute for Integrative Cancer Research, Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Ingrid L ScullyPfizer Vaccine Research and Early Development, Pearl River, New York, USA.
Ross M ZimniskyKoch Institute for Integrative Cancer Research, Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Brinda MonianKoch Institute for Integrative Cancer Research, Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Christina P RossittoKoch Institute for Integrative Cancer Research, Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Ellen B O'ConnellKoch Institute for Integrative Cancer Research, Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Kathrin U JansenPfizer Vaccine Research and Early Development, Pearl River, New York, USA.
Annaliesa S AndersonPfizer Vaccine Research and Early Development, Pearl River, New York, USA.
J Christopher LoveKoch Institute for Integrative Cancer Research, Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA clove@mit.edu.ORCID 0000-0003-0921-3144
Massachusetts Institute of Technology · USPfizer (United States) · USRagon Institute of MGH, MIT and Harvard · US

Funding

Nonhuman Primate Reagent ResourceU24AI126683 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Diogo Magnani · 2016 to 2026
$20.1M
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Immunity, CellularAnimalsAntibody FormationB-LymphocytesCells, CulturedCytokinesHumansStaphylococcal InfectionsStaphylococcal VaccinesStaphylococcus aureusT-Lymphocytes, Helper-InducerVaccinationVaccines, ConjugateCytokinesStaphylococcal VaccinesVaccines, Conjugateimmunizationmemory B cellsmicroengraving

Identifiers

PMID30135219
PMCPMC6106056
OpenAlexW2888521602

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.